ALYN Hospital Receives a $2.2M Grant

To Establish the First Research Center in Israel for Pediatric and Adolescent Rehabilitation

ALYN Hospital, Israel’s first and only pediatric and adolescent rehabilitation facility, has been awarded a donation of $2.189 million from The Leona M. and Harry B. Helmsley Charitable Trust, to establish the first center in Israel dedicated to groundbreaking research that will position Israel as a global leader in pediatric and adolescent rehabilitation development.

The Helmsley Charitable Trust is a global philanthropy committed to helping people live better lives today and creating stronger, healthier futures for individuals and communities. Since 2010, Helmsley has contributed over $434 million to Israel, including a donation of $12.5M last year to help fight the coronavirus pandemic.

ALYN Hospital’s new research center will focus on several relevant fields, including  cognitive, orthopedic and neurological rehabilitation, remote rehabilitation, mobility, and more. These are crucial areas to help ALYN’s young patients perform their daily activities and promote their integration into their communities. These patients are in need of rehabilitation due to various circumstances, such as accidents, diseases, birth defects, and developmental issues (such as cerebral palsy).  With the new research center, ALYN Hospital will be able to advance its treatment methods and approach. The research will be conducted in collaboration with other hospitals and organizations in Israel and around the world.

Arie Melamed, General Manager of ALYNnovation, the hospital’s innovation center, has been appointed as the Director of the Research Center, while Prof. Patrice L. (Tamar) Weiss, a world-renowned expert in the field of rehabilitation, will oversee the center’s scientific activities.

Sandor Frankel, a Helmsley Trustee, stated: “Helmsley is pleased to support ALYN Hospital, a distinguished institution qualified to lead the necessary research activities in the field of pediatric and adolescent rehabilitation in Israel, helping millions of young patients in the country and around the world who need innovative and groundbreaking treatments.”

“The new research center will allow us to expand our research and clinical trials, recruit additional professionals in the field, and continue to advance pediatric and adolescent rehabilitation in Israel and around the world,” says ALYN Hospital’s Director General Dr. Maurit Beeri. “The field of child rehabilitation has not received enough attention due to it being relatively limited,” explains Dr. Beeri. “By establishing this research center at the ALYN Hospital, in collaboration with our best researchers, doctors and senior therapists from various health fields, we will take a major step forward in the fields of research and development of technologies for the rehabilitation of children and adolescents.”

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.